REPLIGEN CORP RGEN

NASDAQ Price as of Nov 10, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$173.97
$100.99
$198.87
Market cap
$11.12B
P/E (GAAP, TTM)
—
P/E (operating)
257.20
Dividend yield
0.0%
Revenue growth YoY
10.9%
EPS growth YoY
-361.5%
ROIC
2.1%
Piotroski F-score
6

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
202.29

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
257.20

After-tax operating income only: the core business.

P/E (excl. gains)
227.45

Net income after removing identified investment and asset-sale gains.

The operating P/E (257.20) is higher than the GAAP P/E (202.29), so net income is boosted by non-operating items such as interest, investment results or one-time items.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) 11.9% 14.8%-2.9 pts ——
EPS growth YoY (qtr) -65.4% 50.0%-115.4 pts ——
Revenue growth (TTM) 16.5% 17.4%-0.9 pts ——
EPS growth (TTM) 384.6% 316.7%+67.9 pts ——
P/E (GAAP, TTM) 259.64 149.86+109.78 ——
P/E (operating) 0.25 0.18+0.07 ——
P/E (excl. gains) 0.22 0.16+0.06 ——
P/B 0.01 0.000.00 ——
ROIC 2.1% 2.1%0.0 pts ——
Net margin 6.6% 6.6%0.0 pts ——
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) 0.74 0.91-18.7% ——
Price $192.13 $136.37+40.9% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $209.31M 2.5% 10.9% -0.68 -855.6% -361.5% -18.4%
Jun 30, 2026 $204.13M 5.1% 11.9% 0.09 -40.0% -65.4% 2.5%
Mar 31, 2026 $194.26M -1.8% 14.8% 0.15 -37.5% 50.0% 4.3%
Dec 31, 2025 * $197.91M 4.8% 18.1% 0.24 -7.7% 139.3% 6.7%
Sep 30, 2025 $188.81M 3.5% 21.9% 0.26 0.0% 2,700.0% 7.9%
Jun 30, 2025 $182.37M 7.8% 14.8% 0.26 160.0% 160.0% 8.2%
Mar 31, 2025 $169.17M 1.0% 10.4% 0.10 116.4% 66.7% 3.4%
Dec 31, 2024 * $167.55M 8.2% 0.6% -0.61 -6,000.0% -110.3% -20.2%
Sep 30, 2024 $154.87M -2.5% 9.7% -0.01 -110.0% -103.3% -0.4%
Jun 30, 2024 $158.84M 3.7% -0.2% 0.10 66.7% -71.4% 3.6%
Mar 31, 2024 $153.18M -8.1% -7.4% 0.06 120.7% -77.8% 2.2%
Dec 31, 2023 * $166.62M 18.0% -10.8% -0.29 -196.7% -134.5% -9.9%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 10, 2026 Date of the latest closing price used.
Price $173.97 Latest closing price.
Market cap $11.12B Price × shares outstanding.
Enterprise value $11.10B Market cap + debt − cash: the price of the whole business.
Shares 63.92M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 202.29 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) 257.20 Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) 777.98 Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 227.45 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 0.4% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -0.1% TTM EPS ÷ price.
P/B 5.28 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 15.06 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 13.80 Market cap ÷ revenue of the last four quarters.
P/FCF 118.44 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 82.87 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT 201.15 Enterprise value ÷ operating income.
EV/Sales 15.03 Enterprise value ÷ revenue.
Book value / share 32.95 Shareholders' equity ÷ shares.
FCF yield 0.8% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS 0.68 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income $7.22M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $209.31M Revenue of the latest reported quarter.
Net income (qtr) -$38.43M Net income of the latest reported quarter.
EPS (qtr) -0.68 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 10.9% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 2.5% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -361.5% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) -855.6% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -357.7% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) -867.4% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -14.1% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -18.4% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $805.61M Revenue of the last four quarters.
Net income (TTM) -$11.80M Net income of the last four quarters.
EPS (TTM) -0.20 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 13.8% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) -2,100.0% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) -779.2% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio 0.0% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 0.0% Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin 52.3% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 18.1% EBITDA ÷ revenue.
Operating margin 7.5% Operating income ÷ revenue.
Net margin 6.6% Net income ÷ revenue.
FCF margin 12.7% Free cash flow ÷ revenue.
ROE 2.3% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 1.7% Return on assets: net income ÷ total assets.
ROIC 2.1% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 16.4% Latest fiscal year revenue vs the year before.
Net income growth (annual) 291.6% Latest fiscal year net income vs the year before.
EPS growth (annual) 287.0% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) -2.7% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) -35.7% Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 8.37 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 7.12 (Current assets − inventory) ÷ current liabilities.
Cash ratio 4.17 Cash ÷ current liabilities.
Debt / equity 0.26 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.18 Total debt ÷ total assets.
Debt / EBITDA 4.05 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA -0.18 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage 2.44 Operating income ÷ interest expense.
Earnings quality
FCF conversion 192.0% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -2.3% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 4.4% Share-based compensation ÷ revenue.
R&D % revenue 7.3% Research & development spending ÷ revenue.
SG&A % revenue 39.4% Selling, general & administrative expense ÷ revenue.
Tax rate used 21.6% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.25 Revenue ÷ total assets.
Days sales outstanding 78 Average days to collect payment from customers.
Days inventory 177 Average days inventory is held.
Days payables 31 Average days to pay suppliers.
Trading & momentum
52-week high $198.87 Highest price in the last 52 weeks.
52-week low $100.99 Lowest price in the last 52 weeks.
From 52-week high -12.5% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 72.3% How far above the 52-week low the price is.
Avg volume (30d) 705.99K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $125.48M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 6 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 8.85 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $738.26M Revenue of the latest fiscal year.
Net income $48.89M Net income of the latest fiscal year.
Diluted EPS 0.86 Diluted earnings per share of the latest fiscal year.
EBITDA $133.91M Operating income + depreciation & amortization.
Free cash flow $93.90M Operating cash flow − capital spending.
Total debt $542.21M Long-term plus current debt.
Cash $566.02M Cash and equivalents.
Equity $2.11B Shareholders' equity.
Total assets $2.95B Total assets.